دورية أكاديمية
Expression of integrin α v β 3 in medullary thyroid carcinoma.
| العنوان: | Expression of integrin α |
|---|---|
| المؤلفون: | de Vries LH; Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Lodewijk L; Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Pijnappel EW; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Schepers A; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2333, ZA Leiden, The Netherlands., Bonenkamp HJ; Department of Surgery, Radboud University Medical Center, Geert Grooteplein 8, 6525, GA Nijmegen, The Netherlands., van Engen-van Grunsven IA; Department of Pathology, Radboud University Medical Center, Geert Grooteplein 8, 6525, GA Nijmegen, The Netherlands., Kruijff S; Department of Surgery, University Medical Center Groningen, Hanzeplein 1, 9700, RB Groningen, The Netherlands., van Hemel BM; Department of Pathology, University Medical Center Groningen, Hanzeplein 1, 9700, RB Groningen, The Netherlands., Links TP; Department of Internal Medicine, University Medical Center Groningen, Hanzeplein 1, 9700. RB Groningen, The Netherlands., Nieveen van Dijkum EJ; Department of Surgery, Amsterdam University Medical Center, location University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, 1105, AZ Amsterdam, The Netherlands., Eeden SV; Department of Pathology, Amsterdam University Medical Center, location University of Amsterdam, Cancer Center Amsterdam, Meibergdreef 9, 1105, AZ Amsterdam, The Netherlands., van Leeuwaarde RS; Department of Endocrine Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Valk GD; Department of Endocrine Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Keizer B; Department of Radiology & Nuclear Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Borel Rinkes IH; Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands., Vriens MR; Department of Surgery, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands. |
| المصدر: | Future oncology (London, England) [Future Oncol] 2024 Aug 05, pp. 1-8. Date of Electronic Publication: 2024 Aug 05. |
| Publication Model: | Ahead of Print |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Future Medicine Ltd Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: London : Future Medicine Ltd., c2005- |
| مستخلص: | Aim: Tumor markers often remain elevated after intended curative resection of medullary thyroid carcinoma (MTC). The aim of this study was to determine the expression of α |
| فهرسة مساهمة: | Keywords: medullary thyroid carcinoma; nuclear imaging; nuclear therapy; tissue microarray; αvβ3 Local Abstract: [plain-language-summary] [Box: see text]. |
| تواريخ الأحداث: | Date Created: 20240805 Latest Revision: 20240805 |
| رمز التحديث: | 20240805 |
| DOI: | 10.1080/14796694.2024.2376511 |
| PMID: | 39101553 |
| قاعدة البيانات: | MEDLINE |
PDF full text from Publisher كن أول من يترك تعليقا!